271 related articles for article (PubMed ID: 11238653)
1. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.
Koelle DM; Chen HB; Gavin MA; Wald A; Kwok WW; Corey L
J Immunol; 2001 Mar; 166(6):4049-58. PubMed ID: 11238653
[TBL] [Abstract][Full Text] [Related]
2. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
Tigges MA; Leng S; Johnson DC; Burke RL
J Immunol; 1996 May; 156(10):3901-10. PubMed ID: 8621929
[TBL] [Abstract][Full Text] [Related]
3. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions.
Koelle DM; Frank JM; Johnson ML; Kwok WW
J Virol; 1998 Sep; 72(9):7476-83. PubMed ID: 9696844
[TBL] [Abstract][Full Text] [Related]
4. Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes.
Posavad CM; Huang ML; Barcy S; Koelle DM; Corey L
J Immunol; 2000 Jul; 165(2):1146-52. PubMed ID: 10878394
[TBL] [Abstract][Full Text] [Related]
5. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
Tabi Z; Moutaftsi M; Borysiewicz LK
J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
[TBL] [Abstract][Full Text] [Related]
7. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
8. Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production.
Mikloska Z; Rückholdt M; Ghadiminejad I; Dunckley H; Denis M; Cunningham AL
J Immunol; 2000 May; 164(10):5167-76. PubMed ID: 10799875
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
Mikloska Z; Cunningham AL
J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4
Srivastava R; Roy S; Coulon PG; Vahed H; Prakash S; Dhanushkodi N; Kim GJ; Fouladi MA; Campo J; Teng AA; Liang X; Schaefer H; BenMohamed L
J Virol; 2019 May; 93(9):. PubMed ID: 30787156
[TBL] [Abstract][Full Text] [Related]
11. Homing in on the cellular immune response to HSV-2 in humans.
Koelle DM; Gonzalez JC; Johnson AS
Am J Reprod Immunol; 2005 Apr; 53(4):172-81. PubMed ID: 15760378
[TBL] [Abstract][Full Text] [Related]
12. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
[TBL] [Abstract][Full Text] [Related]
13. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.
Koelle DM; Tigges MA; Burke RL; Symington FW; Riddell SR; Abbo H; Corey L
J Clin Invest; 1993 Mar; 91(3):961-8. PubMed ID: 8383706
[TBL] [Abstract][Full Text] [Related]
15. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.
Mikloska Z; Kesson AM; Penfold ME; Cunningham AL
J Infect Dis; 1996 Jan; 173(1):7-17. PubMed ID: 8537685
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47.
Jugovic P; Hill AM; Tomazin R; Ploegh H; Johnson DC
J Virol; 1998 Jun; 72(6):5076-84. PubMed ID: 9573278
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
Braun RP; Payne LG; Dong L
Virol J; 2006 Jul; 3():54. PubMed ID: 16822314
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
[TBL] [Abstract][Full Text] [Related]
20. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
